Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Galapagos has said its service division, BioFocus DPI, will supply small molecule compounds for drug discovery to Johnson & Johnson as part of a new agreement.
Subscribe to our email newsletter
Galapagos said it would supply the small molecule compounds to Johnson & Johnson Pharmaceutical research and development division of Janssen Pharmaceutica.
The company said the agreement was a natural expansion of its drug discovery relationship with Johnson & Johnson.
Under the terms of the two-year collaboration, BioFocus DPI will provide access to compounds from its SoftFocus small molecule libraries and will also generate customer specific compound library sets for use in J&J's drug discovery programs. Financial terms of the deal were not disclosed.